Found 15 matching trials
The Hemophilia Inhibitor Prevention Trial PHASE3 This is a multi-center randomized phase III clinical trial, the Inhibitor P...
Show More Location
University of Arkansas Medical Sciences Childrens Hospital
Learn More & Join Trial
Emicizumab in Acquired Hemophilia A PHASE2 This study is an international, multicenter, open-label, single arm, prospe...
Show More Location
Medizinische UniversitÀt Wien, HÀmatologie/HÀmostaseologie
Learn More & Join Trial
Treatment of Hemophilia A Patients With FVIII Inhibitors N/A This is a non-interventional, multicenter, observational, international stu...
Show More Location
Arthur M. Blank Hospital
Learn More & Join Trial
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients PHASE2 Low dose factor VIII prophylaxis is practiced around the world. Role of sta...
Show More Location
Dhaka Medical College Hospital
Learn More & Join Trial
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A PHASE1 Von Willebrand Disease (VWD) is the most common inherited bleeding disorder...
Show More Location
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD)
Learn More & Join Trial
Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform PHASE3 This study will evaluate if Eloctate is superior to Emicizumab in reducing ...
Show More Location
Hemophilia Center of Western Pennsylvania
Learn More & Join Trial
Emicizumab in Patients With Acquired Hemophilia A PHASE2 This is a phase II multicenter open-label, single-arm prospective study to ...
Show More Status
Active Not Recruiting
Location
UCSD Hemophilia and Thrombosis Treatment Center
Learn More & Join Trial
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies PHASE4 This is a prospective, randomized control trial in which each patient will ...
Show More Location
The University of Texas Southwestern Medical Center
Learn More & Join Trial
A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) PHASE3 This study is looking at how safe it is to switch from emicizumab to Mim8, ...
Show More Location
Children's Hospital Los Angeles - Endocrinology
Learn More & Join Trial
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab PHASE4 This is an exploratory, single group, Phase 4, study to assess treatment wi...
Show More Location
Children's Hospital Los Angeles- Site Number : 8400005
Learn More & Join Trial